These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 31836853)
1. Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma. Maura F; Rustad EH; Yellapantula V; Łuksza M; Hoyos D; Maclachlan KH; Diamond BT; Greenbaum BD; Morgan G; Lesokhin A; Papaemmanuil E; Landgren O Leukemia; 2020 May; 34(5):1476-1480. PubMed ID: 31836853 [No Abstract] [Full Text] [Related]
2. Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing. Guo G; Raje NS; Seifer C; Kloeber J; Isenhart R; Ha G; Yee AJ; O'Donnell EK; Tai YT; Richardson PG; Bianchi G; Laubach JP; Warren D; Gemme E; Voisine J; Frede J; Kokkalis A; Yun H; Dimitrova V; Vijaykumar T; Meyerson M; Munshi NC; Anderson KC; Knoechel B; Lohr JG Leukemia; 2018 Aug; 32(8):1838-1841. PubMed ID: 29749395 [No Abstract] [Full Text] [Related]
3. Multiple myeloma clonal evolution in homogeneously treated patients. Corre J; Cleynen A; Robiou du Pont S; Buisson L; Bolli N; Attal M; Munshi N; Avet-Loiseau H Leukemia; 2018 Dec; 32(12):2636-2647. PubMed ID: 29895955 [TBL] [Abstract][Full Text] [Related]
4. The genetic architecture of multiple myeloma. Morgan GJ; Walker BA; Davies FE Nat Rev Cancer; 2012 Apr; 12(5):335-48. PubMed ID: 22495321 [TBL] [Abstract][Full Text] [Related]
5. Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution. Kasar S; Kim J; Improgo R; Tiao G; Polak P; Haradhvala N; Lawrence MS; Kiezun A; Fernandes SM; Bahl S; Sougnez C; Gabriel S; Lander ES; Kim HT; Getz G; Brown JR Nat Commun; 2015 Dec; 6():8866. PubMed ID: 26638776 [TBL] [Abstract][Full Text] [Related]
6. Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation. Chitre S; Stölzel F; Cuthill K; Streetly M; Graham C; Dill C; Mohamedali A; Smith A; Schetelig J; Altmann H; Bornhäuser M; Mufti GJ Leukemia; 2018 Sep; 32(9):2020-2024. PubMed ID: 30026569 [No Abstract] [Full Text] [Related]
7. Accelerated single cell seeding in relapsed multiple myeloma. Landau HJ; Yellapantula V; Diamond BT; Rustad EH; Maclachlan KH; Gundem G; Medina-Martinez J; Ossa JA; Levine MF; Zhou Y; Kappagantula R; Baez P; Attiyeh M; Makohon-Moore A; Zhang L; Boyle EM; Ashby C; Blaney P; Patel M; Zhang Y; Dogan A; Chung DJ; Giralt S; Lahoud OB; Peled JU; Scordo M; Shah G; Hassoun H; Korde NS; Lesokhin AM; Lu S; Mailankody S; Shah U; Smith E; Hultcrantz ML; Ulaner GA; van Rhee F; Morgan GJ; Landgren O; Papaemmanuil E; Iacobuzio-Donahue C; Maura F Nat Commun; 2020 Jul; 11(1):3617. PubMed ID: 32680998 [TBL] [Abstract][Full Text] [Related]
8. High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma. Thakurta A; Ortiz M; Blecua P; Towfic F; Corre J; Serbina NV; Flynt E; Yu Z; Yang Z; Palumbo A; Dimopoulos MA; Gutierrez NC; Goldschmidt H; Sonneveld P; Avet-Loiseau H Blood; 2019 Mar; 133(11):1217-1221. PubMed ID: 30692124 [TBL] [Abstract][Full Text] [Related]
9. Mutational processes contributing to the development of multiple myeloma. Hoang PH; Cornish AJ; Dobbins SE; Kaiser M; Houlston RS Blood Cancer J; 2019 Aug; 9(8):60. PubMed ID: 31387987 [TBL] [Abstract][Full Text] [Related]
10. Boyle EM; Ashby C; Tytarenko RG; Deshpande S; Wang H; Wang Y; Rosenthal A; Sawyer J; Tian E; Flynt E; Hoering A; Johnson SK; Rutherford MW; Wardell CP; Bauer MA; Dumontet C; Facon T; Thanendrarajan S; Schinke CD; Zangari M; van Rhee F; Barlogie B; Cairns D; Jackson G; Thakurta A; Davies FE; Morgan GJ; Walker BA Clin Cancer Res; 2020 May; 26(10):2422-2432. PubMed ID: 31988198 [TBL] [Abstract][Full Text] [Related]